NewLeaf Symbiotics

NewLeaf Symbiotics is an agtech company in St. Louis, United States, founded in 2012. It has raised $161.0M across 8 rounds, most recently a $30.0M Series A in June 2026.

Homepage - NewLeaf

Headquarters
St. Louis
Employees
11–50
Founded
2012
Business Model
B2B
Total Funding
$161.0M
Last Round
$30.0M Series AJun 2026
Rounds
8

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 8 funding rounds and 12 investors for this company. The full record is or through the API.

About

NewLeaf Symbiotics is a biological technology provider. Our specialty is Pink-Pigmented Facultative Methylotrophs, or PPFMs for short. We are the pioneers and global leaders of PPFM technology. Our focus on this microbe and our library of more than 12,000 microbial strains allows us to go deep into their capabilities, harnessing their strength to deliver measurable outcomes in the field. We provide our PPFM technologies to biological manufacturers that sell them at the farm gate. Our portfolio offers eight technologies commercially labeled for 10 crops, and NewLeaf technologies appear in more than 100 brands sold through partners and distributors across the United States.

Summary

It lists 11–50 employees. It has raised $161.0M in total across 8 rounds, most recently a $30.0M Series A round in Jun 2026. Investors include Otter Capital, Cultivian Sandbox Ventures and Fall Line Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AJun 2026
$30.0M

Sign up to see all 8 events

Funding: Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Impossible Foods

Food technology company creating plant-based meat and dairy products that replicate the taste and...

Redwood City, United States501–1000Agtech, Biotech
Series G+Total funding$1.9BNov 2021
Apeel Sciences

Apeel Sciences develops plant-based edible coatings that extend the shelf life of fresh produce, ...

GOLETA, United States201–500Agtech, Biotech
Series FTotal funding$912.9MJul 2025
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

NewLeaf Symbiotics on Indexed.vc
<a href="https://indexed.vc/companies/newleaf-symbiotics"><img src="https://indexed.vc/api/badge/company/newleaf-symbiotics" alt="NewLeaf Symbiotics on Indexed.vc" width="260" height="76" /></a>